Q4 2021 Holdings
Filed 2022-02-14 | 2 holdings | $187.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $187.0M | 2,346,934 | 99.9% |
| Lyell Immunopharma Inc | COM | 55083R104 | $156.1K | 20,162,332 | 0.1% |